The House investigation raises concerns over the drug's approval and cost. A congressional investigation into the Food and Drug Administration's review process for an Alzheimer's treatment found ...

The FDA has approved the anti-amyloid donanemab for early symptomatic Alzheimer's, which includes MCI or mild dementia stage of disease, with confirmed amyloid pathology.

The US Food and Drug Administration (FDA) embraced the use of biomarkers and surrogate endpoints in its most recent guidance on developing therapeutics for early Alzheimer's disease (AD). The ...

This month, the FDA approved a new treatment for Alzheimer’s disease, ... June 7, 2021, shows a vial and packaging for the Alzheimer's drug Aduhelm. Biogen via AP.

Acadia’s clinical-stage pipeline includes drug candidates targeting Prader-Willi syndrome and Alzheimer’s disease psychosis.The company expects to enroll its final patient in its RADIANT Phase ...

INmune Bio Inc. (NASDAQ:INMB) saw its stock plunge 60% in premarket trading Monday, following the release of mixed data from its Phase 2 MINDFuL trial evaluating XPro, a therapy aimed at treating ...

Mayo Clinic's FDA-approved blood test diagnoses Alzheimer's disease with 95% accuracy, offering a less invasive alternative to traditional methods. Alzheimer’s diagnosis blood test gets high ...

Jeff Dage, a senior research professor of neurology at the IU School of Medicine, has developed a blood test that’s more than 90% accurate in diagnosing Alzheimer’s disease.In May, that blood ...